Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators.
N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145.
Brain stimulation treatment for bipolar disorder.
Mutz J.
Bipolar Disord. 2023 Feb;25(1):9-24. doi: 10.1111/bdi.13283. Epub 2022 Dec 21.
Cognitive dysfunctions in depression - significance, description and treatment prospects.
Czerwińska A, Pawłowski T.
Psychiatr Pol. 2020 Jun 30;54(3):453-466. doi: 10.12740/PP/OnlineFirst/105415. Epub 2020 Jun 30.
Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group.
Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, Aftanas L, Aghajani M, Aleman A, Baune BT, Berger K, Brak I, Filho GB, Carballedo A, Connolly CG, Couvy-Duchesne B, Cullen KR, Dannlowski U, Davey CG, Dima D, Duran FLS, Enneking V, Filimonova E, Frenzel S, Frodl T, Fu CHY, Godlewska BR, Gotlib IH, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Hall GB, Harrison BJ, Hatton SN, Hermesdorf M, Hickie IB, Ho TC, Hosten N, Jansen A, Kähler C, Kircher T, Klimes-Dougan B, Krämer B, Krug A, Lagopoulos J, Leenings R, MacMaster FP, MacQueen G, McIntosh A, McLellan Q, McMahon KL, Medland SE, Mueller BA, Mwangi B, Osipov E, Portella MJ, Pozzi E, Reneman L, Repple J, Rosa PGP, Sacchet MD, Sämann PG, Schnell K, Schrantee A, Simulionyte E, Soares JC, Sommer J, Stein DJ, Steinsträter O, Strike LT, Thomopoulos SI, van Tol MJ, Veer IM, Vermeiren RRJM, Walter H, van der Wee NJA, van der Werff SJA, Whalley H, Winter NR, Wittfeld K, Wright MJ, Wu MJ, Völzke H, Yang TT, Zannias V, de Zubicaray GI, Zunta-Soares GB, Abé C, Alda M, Andreassen OA, Bøen E, Bonnin CM, Canales-Rodriguez EJ, Cannon D, Caseras X, Chaim-Avancini TM, Elvsåshagen T, Favre P, Foley SF, Fullerton JM, Goikolea JM, Haarman BCM, Hajek T, …
Mol Psychiatry. 2021 Sep;26(9):5124-5139. doi: 10.1038/s41380-020-0754-0. Epub 2020 May 18.
The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review.
Sinyor M, Schaffer A, Levitt A.
Can J Psychiatry. 2010 Mar;55(3):126-35. doi: 10.1177/070674371005500303.
Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder.
Zuckerman H, Pan Z, Park C, Brietzke E, Musial N, Shariq AS, Iacobucci M, Yim SJ, Lui LMW, Rong C, McIntyre RS.
Front Psychiatry. 2018 Dec 4;9:655. doi: 10.3389/fpsyt.2018.00655. eCollection 2018.
Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.
Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, Hayes R, Huijbers M, Ma H, Schweizer S, Segal Z, Speckens A, Teasdale JD, Van Heeringen K, Williams M, Byford S, Byng R, Dalgleish T.
JAMA Psychiatry. 2016 Jun 1;73(6):565-74. doi: 10.1001/jamapsychiatry.2016.0076.
Cognitive performance in antidepressant-free recurrent major depressive disorder.
Albert KM, Potter GG, McQuoid DR, Taylor WD.
Depress Anxiety. 2018 Aug;35(8):694-699. doi: 10.1002/da.22747. Epub 2018 Apr 10.
Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
Moriarty AS, Meader N, Snell KI, Riley RD, Paton LW, Chew-Graham CA, Gilbody S, Churchill R, Phillips RS, Ali S, McMillan D.
Cochrane Database Syst Rev. 2021 May 6;5(5):CD013491. doi: 10.1002/14651858.CD013491.pub2.
Neuroprogression and Immune Activation in Major Depressive Disorder.
Meyer JH.
Mod Trends Pharmacopsychiatry. 2017;31:27-36. doi: 10.1159/000470804. Epub 2017 Jul 24.
